INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 421m ago
HOUSE PTR21m ago
SEC 13F21m ago
ROBINHOOD CHAIN21m ago
Corporate insider
KP

Kowalsky Matthew Paul

Chief Legal OfficerCIK 0001705824

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score21
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KP
Kowalsky Matthew PaulChief Legal Officer
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
1,318 sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    ENANTA PHARMACEUTICALS INCChief Legal Officer · Nov 26, 2025
21
KP
Kowalsky Matthew PaulChief Legal Officer
ENTAENANTA PHARMACEUTICALS INC
Tax withholding
F
$27K
1,902 sh
Feb 12, 2026
Feb 13, 2026
traded Feb 12, 2026
+1d
SEC FORM 4

Evidence

21
KP
Kowalsky Matthew PaulChief Legal Officer
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
4,175 sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC FORM 4

Evidence

9
KP
Kowalsky Matthew PaulChief Legal Officer
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
90.0K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC FORM 4

Evidence